Explaining risks and benefits of loco-regional treatments to patients
Breast. 2023 Aug 22;71:132-137. doi: 10.1016/j.breast.2023.08.006. Online ahead of print.ABSTRACTTreatment for early-stage breast cancer is complex, requiring multidisciplinary care with a multitude of treatment options available for each patient. Coupled with the rising importance of shared decision-making, patient-physician conversations are progressively more complicated. These conversations require frank disclosure of risks and benefits of the different treatment modalities in a way that is individualized for each patient and simple to understand. In most patients, breast conserving therapy with radiation should be presented as the gold-standard local treatment given similar long-term and improved quality of life outcomes. De-escalation is currently at the forefront of research in loco-regional treatments, and further investigations are required to best determine the optimal patient populations for reduced sentinel lymph node sampling, omission of sentinel lymph node biopsy altogether and omission of radiation treatment. For future trials, better endpoints need to be established considering patient-centered outcomes as well as recurrence.PMID:37634470 | PMC:PMC10472006 | DOI:10.1016/j.breast.2023.08.006
Source: Breast - Category: Cancer & Oncology Authors: Ana-Alicia Beltran-Bless Stephanie Kacerovsky-Strobl Michael Gnant Source Type: research